Author: GlobeNewswire

Acquisition builds on LianBio’s existing partnership with Pfizer to bring novel therapeutics to Greater ChinaSHANGHAI AND PRINCETON, N.J., April 07,…

LA JOLLA, Calif., April 07, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…

VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTC: AGFAF)…

NEWPORT BEACH, Calif., April 07, 2022 (GLOBE NEWSWIRE) — GABA Therapeutics, Inc, (“GABA”) a clinical-stage biotechnology company developing novel therapies…

STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today…

CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to design…

CAMBRIDGE, Mass. and NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology…

WATERTOWN, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta” or the “Company”), a biotechnology company…

CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced publication in The New England Journal…

Biomea to present additional preclinical data from an in vivo study of BMF-219 in type 2 diabetes REDWOOD CITY, Calif., April…